Nasdaq Hits 17k, But the Market Was Red | Wall Street Today
The Nasdaq broke records Tuesday, jumping over 17k for the first time before pulling back following a three-day break for Memorial Day. The index hit an all-time closing high of 17,019. Still, by the numbers, about 2,000 more equities were declining than climbing.
What's Going On With Moderna Stock Today?
Moderna Inc. (NASDAQ:MRNA) shares are trading lower Tuesday. The stock may be pulling back after gaining on bird flu concerns last week and predictions for a slight rise in COVID-19 cases.What's Going
Arcturus Therapeutics' Early Cystic Fibrosis Trial Results Encouraging - Analyst Cautiously Optimistic
On Tuesday, Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) announced that it will present Phase 1 results in healthy volunteers and new Phase 1b interim data in cystic fibrosis (CF) for ARCT-032 at
US Stocks Waver, Nvidia Lifts Chipmaker Boats, GameStop Spikes, Moderna Tumbles: What's Driving Markets Tuesday?
Wall Street resumed trading after the Memorial Day holiday with a familiar trend, as major chipmaker stocks significantly outperformed the broader market.Nvidia Corp. (NASDAQ:NVDA) shares surged over
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) fell sharply during Tuesday's session after the company announced the pricing of a $12 million public offering.Applied DNA Sciences shares tumbled 67
Nasdaq Hitting Highs, Market Flat | Herd On Wall Street
Morning mooers! Happy Tuesday, May 28th. The market is open after a three-day holiday in memory of those who gave their lives for the U.S. The Nasdaq broke records Tuesday, jumping over 17k for the first time.
Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Tuesday.Shares of NVIDIA Corporation (NASDAQ:NVDA) rose during Tuesday's session on reports Elon Musk's xAI plans to bu
Why Mid-Cap Corcept Therapeutics Stock Trading Higher On Tuesday?
Tuesday, Corcept Therapeutics Incorporated (NASDAQ:CORT) announced that the GRACE Phase 3 trial of relacorilant in patients with hypercortisolism (Cushing's syndrome) met its primary endpoint.In April
Market-Moving News for May 28th
CORT: 41% | Corcept Therapeutics shares are trading higher after the company announced that its Phase 3 GRACE trial met its primary endpoint.ARCT: 21% | Arcutus Therapeutics Holdings shares are tradin
Corcept Climbs as Late-stage Trial for Cushing's Syndrome Therapy Succeeds
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersSharps Technology (NASDAQ:STSS) shares rose 193.0% to $0.63 during Tuesday's pre-market session. The market value of their outstanding shares is at $9.8 million. Insmed (NASDAQ:INSM) shares mov
Ford Motor, Microsoft And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by around 1% on Friday. Investors, meanwhile, focused on some notable insider trades.When insiders sell shares, it could be a preplanned sale, or could indicate their conc
HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $113 Price Target
HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $113 price target.
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In Your Portfolio?
These large-cap stocks were the best performers in the last week. Are they in your portfolio?First Solar, Inc. (NASDAQ:FSLR) shares jumped 41.5% possibly in response to President Joe Biden's recent an
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Thursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 trial evaluating avutometinib plus defactinib in combination wit
Critical Insights From BioNTech Analyst Ratings: What You Need To Know
Across the recent three months, 11 analysts have shared their insights on BioNTech (NASDAQ:BNTX), expressing a variety of opinions spanning from bullish to bearish.In the table below, you'll find a su
BioNTech Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/24/2024 14.66% HC Wainwright & Co. → $113 Reiterates Buy → Buy 05/14/2024 1.47% Evercore ISI Group → $1
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Financial giants have made a conspicuous bullish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex Pharmaceuticals (NASDAQ:VRTX) revealed 16 unusual trades.Delving into the de